This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.81% per year. These returns cover a period from January 1, 1988 through September 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Is First Trust Dow 30 Equal Weight ETF (EDOW) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for EDOW
JOLTS Posts Bigger Numbers; CRM, OKTA Beat in Q3
by Mark Vickery
The S&P 500 and Nasdaq continue to post new all-time closing highs.
Compared to Estimates, Salesforce.com (CRM) Q3 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for Salesforce.com (CRM) give insight into how the company performed in the quarter ended October 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Salesforce.com (CRM) Q3 Earnings Lag Estimates
by Zacks Equity Research
Salesforce.com (CRM) delivered earnings and revenue surprises of -0.82% and 1.13%, respectively, for the quarter ended October 2024. Do the numbers hold clues to what lies ahead for the stock?
Should You Buy, Sell, or Hold Docusign Stock Before Q3 Earnings?
by Shuvra Shankar Dey
DOCU's third-quarter fiscal 2025 earnings and revenues are likely to increase year over year.
Historical Odds Favor Year-End Rally: Stocks to Watch
by Bryan Hayes
If we finish in this territory, it would be the first time since 1998-99 that the S&P 500 rose 20% or more in consecutive years.
Markets Await More Economic Data
by Zacks Equity Research
Markets Await More Economic Data
Pre-markets Flat Ahead of JOLTS Data
by Mark Vickery
Pre-market futures are flat as a pancake at this hour, with none of the major indexes either up or down 0.1% currently.
Should Invesco Large Cap Growth ETF (PWB) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for PWB
Should You Invest in the iShares Expanded Tech-Software Sector ETF (IGV)?
by Zacks Equity Research
Sector ETF report for IGV
Will Slower Sales Growth Dent Salesforce's Earnings This Season?
by Zacks Equity Research
CRM's decelerating revenue growth amid cautious IT spending could weigh on its third-quarter fiscal 2025 earnings despite a projected EPS uptick.
Stock Market News for Nov 29, 2024
by Zacks Equity Research
U.S. stocks ended lower on Thanksgiving Eve, with tech stocks leading the decline, as a jump in October inflation raised concerns that the Federal Reserve could take a cautious approach to future rate cuts.
Salesforce Set to Report Q3 Earnings: Buy, Sell or Hold the Stock?
by Anirudha Bhagat
CRM's Q3 performance is likely to reflect the benefits of the growing adoption of generative AI-enabled solutions and the continued cloud migration.
Gear Up for Salesforce.com (CRM) Q3 Earnings: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for Salesforce.com (CRM), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended October 2024.
5 Spectacular Earnings Charts to Finish Earnings Season
by Tracey Ryniec
DELL, CRWD, CRM, LULU and ULTA are true earnings all-stars.
Salesforce.com (CRM) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Salesforce.com (CRM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Wall Street Analysts Think Salesforce.com (CRM) Is a Good Investment: Is It?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Salesforce.com (CRM) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Salesforce.com (CRM) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Salesforce.com (CRM) concluded the recent trading session at $339.11, signifying a -0.85% move from its prior day's close.
Docusign Stock Rises 20% in a Month: Should You Hold or Fold?
by Shuvra Shankar Dey
With DOCU shares witnessing a substantial surge, it's crucial to evaluate the stock's current position and its investment appeal.
Salesforce Inc. (CRM) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Salesforce.com (CRM). This makes it worthwhile to examine what the stock has in store.
Should First Trust Dow 30 Equal Weight ETF (EDOW) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for EDOW
Salesforce.com (CRM) Stock Slides as Market Rises: Facts to Know Before You Trade
by Zacks Equity Research
Salesforce.com (CRM) reachead $322.25 at the closing of the latest trading day, reflecting a -0.93% change compared to its last close.
Reasons Why You Should Hold DocuSign Stock in Your Portfolio
by Zacks Equity Research
DOCU is experiencing a rise in customer demand for eSignature and benefiting from adopting a subscription model.
Workday Gains 17% in the Past Year: Reason to Buy WDAY Stock?
by Supriyo Bose
With solid fundamentals and healthy revenue-generating potential driven by robust demand trends, WDAY appears to be a solid investment proposition.
Five9 Collaborates With ServiceNow: Should Investors Buy the Stock?
by Zacks Equity Research
FIVN's collaboration with ServiceNow to integrate a comprehensive AI-empowered solution may bode well for the stock.